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SUPPLEMENTARY METHODS 
S.1. Analytical description of tissue organisation 
With the basic assumptions described in section 3.1 and Fig. 1, yhe 1-neighbourhood of an 
individual cell will contain 6 adjacent cells within the plane and 2 polar cells, one at the top and 
one at the bottom of the reference cell. The 2-neighbourhood will contain 12 cells within the 
plane, 6 cells in the above and bottom layers and two polar cells. The 3-neighbourhood will 
have 18 cells within the plane, 24, 12, 6 and 2 in the other layers. By induction, we infer that 
the k-neighbourhood of an individual cell in such tessellation is made of ks0 cells within the 
plane, the sum of is0 for each of the above and below layers, with i from 1 to k-1, and the two 
polar cells: 
 𝐶𝑘 = 𝑘𝑠0 + 2∑ 𝑖𝑠0
𝑘−1
𝑖=1 + 2 Eq. S1.1 
To simplify, ks0 (s0 here is 6) can be brought within the sum, then allowing to simplify to the 
correspondent triangular number: 
 𝐶𝑘 = −𝑘𝑠0 + 2∑ 𝑖𝑠0
𝑘
𝑖=1 + 2 = 𝑘
2𝑠0 + 2 Eq. S1.2 
It should be noted that for intercalated layers, the coordination values can be larger.  
Another example, this time including a significant constraint in topology, is represented by the 
same topology, where only three layers are considered. 
 𝐶1 = 𝑠0 + 2 Eq. S1.3 
 𝐶𝑘>1 = 𝑘𝑠0 + 2(𝑘 − 1)𝑠0 = 𝑠0(3𝑘 − 2) Eq. S1.4 
 
S.2. Probability of initiation (power function) 
Let’s assume the probability of tumour initiation is proportional to a concentration gradient, 





 Eq. S.2.1 
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Where pn0 indicate the probability of tumour initiation when cells are attached (the 1-
neighbourhood). Therefore, in the case of 3D hexagonal tessellation, we can derive the factor 
Cpn: 




𝑘=1  Eq. S.2.2 
This sum is carried over an infinite neighbourhood, and the validity of the results will be 
checked numerically (see Section 3.2 and Fig. 2). First, we can expand ptn: 
 Ω = 𝑠0∑ 𝑘
2−𝑙∞
𝑘=1 + 2∑ 𝑘
−𝑙∞
𝑘=1  Eq. S.2.3 
These series can now be described by Riemann Zeta functions: 
 Ω = 𝑠0𝜁(𝑙 − 2) + 2𝜁(𝑙) Eq. S.2.4 
Let’s now consider the thin 3-layer tissue which tessellation was already discussed. In this 
case, for one cell:  








𝑘=1   Eq. S.2.5 
Following the same process described before, we can obtain: 








𝑘=1   Eq. S.2.6 
And,  
 Ω = 18𝜁(𝑙 − 1) − 12𝜁(𝑙) + 2  Eq. S.2.7 
This describe the probability of transformation for a cell in the middle layer. We can 
approximate the result over the tissue equal to this value by N/3 (middle layer) and with half 
contribution for the top and bottom layer resulting in 
 Ω = 12𝜁(𝑙 − 1) − 8𝜁(𝑙) + 4/3  Eq. S.2.8 
 
S.3. Probability of initiation (exponential function) 
Let’s now assume the oncogenic field decays as an exponential function: 
 𝑝𝑛𝑘 = 𝑝𝑛0𝑒
−(𝑘−1)𝑘𝑐
−1
 Eq. S.3.1 
Where kc is a decay constant expressed in terms of k-neighbourhood for simplicity. If two cells 
are in contact, the probability of initiation will be pn0 as per definition of pn0. When cells are at 
a kc+1 distance, this probability is 1/e lower, i.e. ~30% lower. In the case of 3D hexagonal 
tessellation, the factor 𝐶𝑝𝑛 can be now expressed as: 
 Ω = ∑ (𝑘2𝑠0 + 2)𝑒
−(𝑘−1)𝑘𝑐
−1∞
𝑘=1  Eq. S.3.2 
Or the sum of the series: 
 Ω = 2∑ 𝑒−(𝑘−1)𝑘𝑐
−1∞
𝑘=1 + 𝑠0∑ 𝑘
2𝑒−(𝑘−1)𝑘𝑐
−1∞
𝑘=1  Eq. S.3.3 




























3  Eq. S.3.5 
Therefore,  











3  Eq. S.3.6 
With s0 = 6, once again to confirm mathematical consistency, lim
𝑘𝑐→0
Ω = 8, as in the case where 
only adjacent cells are important. Shallower decays will again increase this value (see Fig. 2).  
 
S.4 Probability of initiation (generalisation) 
We have characterised the oncogenic field in relation to typical descriptions of morphogenic 
gradients [22]. While relevant for specific cases, steady-state concentration gradients of 
shared resources in space, generated by passive diffusion and linear or non-linear 
degradation, can adopt different shapes. One useful analytical description is represented by 







 Eq. S.4.1 
With the same formalism and strategies described in Sections S.2 and S.3 we can show that, 
for a three-dimensional tissue: 
 Ω = ∑ (𝑘2𝑠0 + 2)𝑘
−𝑙𝑒−(𝑘−1)𝑘𝑐
−1∞
𝑘=1  Eq. S.4.2 
This analytical representation of Ω can be expressed as sums of polylogarithm functions:  








)] Eq. S.4.3 
This representation converges to those shown in Sections S.2 and S.3 in the cases where kc 
is very large or where l is very small, respectively, i.e. when the power-law or the exponential 
decay components are negligible. The case l=1 represents an oncogenic field induced by 
continuous point-sources in an unconstrained three-dimensional space in the presence of 
linear degradation. In this geometry: 










2] Eq. S.4.4 
 
S.5. Cell-autonomous time-horizon (discrete-time Markov chain) 
The mutational process illustrated in this work can be modelled as a discrete-time Markov 
process (see also Sup. File ‘firstpassageproblem_v2.nb’ or ‘firstpassageproblem_v2.pdf’ 
in the GitHub repository alesposito/CloE-PE  [50] for the Mathematica Notebook used in this 
work and the peer-review open documentation for related discussion). Each cell is 
described by four states: wild-type (W), mutant X, mutant Y, and double-mutant (XY). At any 




 𝑇 = (
1 − (𝑥 + 𝑦)𝜌0 − 𝑥𝑦𝜌0
2 𝑥𝜌0 𝑦𝜌0 𝑥𝑦𝜌0
2
0 1 − 𝑦𝜌0 0 𝑦𝜌0
0 0 1 − 𝑥𝜌0 𝑥𝜌0
0 0 0 1
) Eq. S.5.1 
where the probability of acquiring the mutation X or Y are independent and directly proportional 
to the mutational rate 𝜌0 with proportionality constants x and y, respectively. Initially, the 
system is described by the state vector 𝑆0 = (1 0 0 0), i.e. all cells are wild-type. The 
probability of observing a double-mutant XY at day t (with 𝑡 ∈ ℕ) is: 














 Eq. S.5.2 
As 𝜌0 ≪ 1, 𝑝𝑋𝑌(𝑡) can be well-approximated with a second-order (or the order matching the 
number of mutations for Eq. S.5.9) element of a Taylor series: 
 𝑝𝑋𝑌(𝑡) ≈ t
2𝑥𝑦𝜌0
2 Eq. S.5.3 
The probability of not observing any XY mutant in a population of N cells will be therefore 
(1 − t2𝑥𝑦𝜌0
2)𝑁, and the probability of observing a double-mutant after t days will be thus: 
 𝑃𝑋𝑌(𝑡) ≈ 1 − (1 − t
2𝑥𝑦𝜌0
2)𝑁 ≈ 1 − e−t
2𝑁𝑥𝑦𝜌0
2
 Eq. S.5.4 









 Eq. S.5.5 
The expectation for the average latency of the first double-mutant XY can be then evaluated 
as: 









 Eq. S.5.6 
For a two-hits model, the cell-autonomous time-horizon (ta) and the time at which the first CD 
clone might appear can be then described by Eq. S.5.6 with x=1, and y=1 or y=Ω, respectively. 














−0.5 Eq. S.5.8 
We note that the scaling factor Ω−0.5 in Eq. S.5.8 is the factor (xy)-1/2 in Eq. S.5.6 with x=1 and 
y=Ω. In the Mathematica notebook we also show that for three mutations (X, Y, Z) the scaling 
factors is (xyz)-1/3. We infer that if we define an average or apparent oncogenic field effect Ω, 
the scaling factor between the first passage time of a clones cooperating by paracrine effects 
and clone accruing a similar number of mutations within a single cell would be of the form: 
 Ω−
𝑑
𝑚⁄  Eq. S.5.9 
in which m is the number of mutations required for transformation and d is the number of 
mutations which effect is mediated through, for example, diffusible molecules.  
